Rx Medicare

Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical company, and Astellas Pharma U.S., Inc. (“Astellas”) announced the U.S. commercial launch of SUMAVEL? DosePro? (sumatriptan injection) needle-free delivery system. In July 2009, the U.S…

Read More…

Related Posts

• Tapentadol Tablets For Moderate To Scute Pain In Over 18s Now Available For Use In The United States
• First Results In United States In 20 Years From Clinical Trials Of Smoked Cannabis
• Training in childhood obesity management in the United States: a survey of pediatric, internal medicine-pediatrics and family medicine residency program directors
• Discrimination against international medical graduatesin the United States residency program selection process
• Why Light Worsens Migraine Headaches
• Treating Cluster Headaches With High-Flow Oxygen Appears Effective
• Severity Of Swine Flu In The United States
• What Are Cluster Headaches? What Causes Cluster Headaches?
• For Severe Migraine Headaches, Surgery Potentially The Best Option
• Zogenix And Astellas Announce Data Published Showing The Benefits Of SUMAVEL(TM) DosePro(TM) Needle-Free Delivery System
• United States In “Good Shape” For Flu Season, Says MIT Sloan Expert
• NuPathe Reports Positive Phase III Results For Zelrix, A Novel Transdermal Patch For Acute Migraine
• New Hope For Migraine Sufferers: Forehead Lifts Can Erase Years And Headaches
• NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
• Common Migraine Pain Condition Also Prevalent In Cluster Headache

Tags: acute, available, cluster, doseprotm, headaches, migraine, states, sumaveltm, treat, united

This entry was posted on Saturday, January 16th, 2010 at 6:01 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.